Abstract
In order to study the effect of c-Myc activation in T lymphocytes in vivo, we generated transgenic mice that express a 4-hydroxytamoxifen (4-OHT)-dependent switchable c-myc oncoprotein under the control of the proximal lck promoter. Activation of c-MycERTM causes no obvious alteration in T cell ontogeny. However, using MHC class I restricted H-Y-TCR transgenic mice, we found that c-Myc activation in vivo enhances the efficiency of positive selection. Moreover, splenic T cells derived from lck-c-mycERTM transgenic mice in which c-Myc had been activated exhibited increased proliferation in vitro in response to activation with anti-CD3/CD28 antibody. Activation of c-MycERTM also promotes apoptosis in thymocytes in vitro.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD and Brinster RL . 1985 Nature 318: 533–538
Alarcon RM, Rupnow BA, Graeber TG, Knox SJ and Giaccia AJ . 1996 Cancer Res 56: 4315–4319
Amati B, Dalton S, Brooks M, Littlewood T, Evan G and Land H . 1992 Nature 359: 423–426
Amati B and Land H . 1994 Curr Opin Genet Dev 4: 102–108
Amati B, Littlewood TD, Evan GI and Land H . 1993 EMBO J 12: 5083–5087
Askew D, Ashmun R, Simmons B and Cleveland J . 1991 Oncogene 6: 1915–1922
Ayer DE, Kretzner L and Eisenman RN . 1993 Cell 72: 211–222
Bissonnette R, Echeverri F, Mahboubi A and Green D . 1992 Nature 359: 552–554
Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN and Weintraub H . 1990 Science 250: 1149–1151
Blackwood EM and Eisenman RN . 1991 Science 251: 1211–1217
Bluthmann H, Kisielow P, Uematsu Y, Malissen M, Krimpenfort P, Berns A, von Boehmer H and Steinmetz M . 1988 Nature 334: 156–159
Brinster RL, Chen HY, Trumbauer ME, Yagle MK and Palmiter RD . 1985 PNAS 82: 4438–4442
Broussard-Diehl C, Bauer SR and Scheuermann RH . 1996 J Immunology 156: 3141–3150
Calan BJ, Szychowski S, Chan FKM, Cado D and Winoto A . 1995 Immunity 3: 273–282
Carding S and Reem GH . 1987 Thymus 10: 219–229
Chaffin KE, Beals CR, Wilkie TM, Forbusch KA, Simon MI and Perlmutter RM . 1990 EMBO J 9: 3821–3829
Cole M . 1986 Annu Rev Genet 20: 361–384
Davis AC, Wims M, Spotts GD, Hann SR and Bradley A . 1993 Genes Dev 7: 671–682
Eilers M, Schirm S and Bishop JM . 1991 EMBO J 10: 133–141
Evan GI, Hancock D and Littlewood T . 1985 Elsevier Sciences, Hameenlinna
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC . 1992 Cell 63: 119–125
Fanidi A, Harrington E and Evan G . 1992 Nature 359: 554–556
Furr BJ, Patterson JS, Richardson DN and Slater SR . 1979 Pharm Biochem Prop Drug Subst 2: 355–399
Harrington EA, Bennett MR, Fanidi A and Evan GI . 1994 EMBO J 13: 3286–3295
Heikkila R, Schwab G, Wickstrom E, Loke S, Pulznik D, Watt R and Neckers L . 1987 Nature 328: 445–449
Hueber A-O, Zörnig M, Lyon D, Suda T, Nagata S and Evan G . 1997 Science 278: 1305–1309
Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG, Jenkins NA and Eisenman RN . 1995 EMBO J 14: 5646–5659
Juin P, Hueber A-O, Littlewood T and Evan G . 1999 Genes Dev 13: 1367–1381
Kelly K and Siebenlist U . 1986 Annu Rev Immunol 4: 317–338
Kisielow P, Bluethmann U, Staerz D, Steinmetz M and von Boehmer H . 1988 Nature 333: 742
Klefstrom J, Vastrik I, Saksela E, Valle J, Eilers M and Alitalo K . 1994 EMBO J 15: 5442–5450
Littlewood TD, Hancock DC, Danielian P, Parker MG and Evan GI . 1995 Nucl Acids Res 23: 1686–1690
Lucas B, Vasseur F and Penit C . 1998 J Immunol 151: 4574–4582
Lyons AB and Parish CR . 1994 J Immunol Methods 171: 131–137
Marrack P, Winslow GM, Choi Y, Scherer M, Pullen A, White J and Kappler JW . 1993 Immun Rev 131: 79–92
Miyazaki T and Lemonnier FA . 1998 J Exp Med 4: 715–723
Pelengaris S, Littlewood T, Khan M, Elia G and Evan GI . 1999 Molec Cell 3: 565–577
Robey EA, Ramsdell F, Gordon JW, Mamalaki C, Kioussis D, Youn HJ, Gottlieb PD, Axel R and Fowlkes BJ . 1992 Int Immunol 155: 969–974
Sambrook J, Fritsch EF and Maniatis T . 1989 Second Edition Cold Spring Harbor Laboratory Press
Shortman K, Egerton M, Spangrude GJ and Scollary R . 1990 Sem Immunol 2: 3–12
Spanopoulou E, Early A, Elliot J, Crispe N, Ladyman H, Ritter M, Watt S, Grosveld F and Kioussis D . 1989 Nature 342: 185–189
Spencer CA and Groudine M . 1991 Adv Cancer Res 56: 1–48
Stewart M, Cameron E, Campbell M, Mcfarlane R, Toth S, Lang K, Onions D and Neil JC . 1993 Int J Cancer 53: 1023–1030
Surh CD and Sprent J . 1994 Nature 372: 100–103
Teh HS, Kishi H, Scott B and von Boehmer H . 1989 J Exp Med 169: 795–806
Teh HS, Kisielow P, Scott B, Kishi H, Uematsu Y, Bluthmann H and von Boehmer H . 1988 Nature 335: 229–233
Tough D and Sprent J . 1994 J Exp Med 179: 1127–1135
von Boehmer H . 1990 Annu Rev Immunol 8: 531–556
Wagner AJ, Small MB and Hay N . 1993 Mol Cell Biol 13: 2432–2440
Watanabe M, Tanaka H, Koizumi H, Tanimoto Y, Tony R and Yanagita T . 1980 Jitchuken Zenrinsho Kenkyyicho 6: 1–36
Wells AD, Gudmondsdottir H and Turka LA . 1997 J Clin Invest 100: 3173–3183
Wildin RS, Garvin AM, Pawar S, Lewis D, Abraham KM, Forbusch KA, Ziegler SF, Allen JM and Perlmutter RM . 1991 J Exp Med 173: 383–393
Zervos AS, Gyuris J and Brent R . 1993 Cell 72: 223–232
Acknowledgements
B Rudolph was supported by a DFG Postdoktoranden Stipendium and a Marie Curie TMR fellowship (ERBFMBICT961770). A-O Hueber was a recipient of a long-term EMBO fellowship. We are grateful for support from the Royal Society and from EC BioTech Grant BIO4-CT96-0052. In addition, we thank T Crafton and her team for excellent support with animal work and J Bee and G Hutchinson for the IP injections. We are grateful to Trevor Littlewood and Doreen Cantrell for critical reading of the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rudolph, B., Hueber, AO. & Evan, G. Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro. Oncogene 19, 1891–1900 (2000). https://doi.org/10.1038/sj.onc.1203508
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203508
Keywords
This article is cited by
-
The transcriptional landscape of αβ T cell differentiation
Nature Immunology (2013)
-
Expression of Mad1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation
Oncogene (2001)